PRESCRIBING · PART D · 2024
Total Rx claims
11
Beneficiaries
—
Total drug cost
$7K
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Rivaroxaban11 claims
QUALITY · MIPS · 2024
Final MIPS score
83.9
Quality
75.0
Cost
88.3
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.37%
Group
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CROSS-REFERENCE